
✓
Open
12 Jun 2019
✓
Close
21 Jun 2019
3
Allotment
—
4
Listing
Tue, Jun 25, 2019T
Price Band
₹72 per share
Issue Size
34,40,000 shares (agg. up to ₹25 Cr)
Lot Size
1,600 Shares
Listing Date
Tue, Jun 25, 2019T
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2019 | 31 Mar 2018 | 31 Mar 2017 |
|---|---|---|---|
| Assets | 50.14 | 30.96 | 19.93 |
| Total Income | 140.02 | 89.76 | 55.52 |
| Profit After Tax | 2.35 | 0.74 | 0.16 |
| NET Worth | 18.74 | 8.54 | 3.21 |
| Reserves and Surplus | 9.20 | 3.82 | 1.04 |
| Total Borrowing | 16.95 | 10.29 | 5.77 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Deep Polymers Ltd. | SME | ₹15.24 Cr | ₹40 | null | ₹40.90 | +2.25% | ₹36.70 (+0.80%) |
| Ambani Organics Ltd. | SME | ₹9.03 Cr | ₹66 | null | ₹66.65 | +0.98% | ₹118.00 (+2.56%) |
| Neogen Chemicals Ltd. | Mainboard | ₹132.35 Cr | ₹215 | null | ₹263.55 | +22.58% | ₹2,175.60 (-5.96%) |
| Fine Organic Industries Ltd. | Mainboard | ₹600.17 Cr | ₹783 | null | ₹822.80 | +5.08% | ₹5,056.00 (-0.32%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To set up a dedicated manufacturing facility for Pharmaceutical Business | 12.50 |
| 2 | Distribution and Warehousing Centre‘s & Purchase of Corporate Office | 4.50 |
| 3 | Additional Working Capital | 5.25 |
| 4 | General Corporate Expenses | 2.80 |
About Sudarshan Pharma Industries IPO
Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad. The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions. The competitive strengths of the company are:1. Customer
Contact Details
Sudarshan Pharma Industries Ltd. Address301, 3rd Floor, Aura Biplex,Above Kalyan Jewellers, S V Road,Borivali (West), MumbaiBorivali, Maharashtra, 400092+91 22 242221111compliance.spil@gmail.comVisit Website